Should Caffeine Be a Regulated Substance?

Feb. 25, 2013 - PRLog -- New Rochelle, NY–Caffeine-related toxicity, deaths, and near-deaths are an undeniable fact. In Sweden, for example, four people died as a result of confirmed caffeine-related causes in one year. Yet caffeine use continues to grow, including among young people, as it is increasingly added to a variety of drinks, foods, and weight-loss and other commonly used products. The debate over calls to regulate caffeine rises to a new level of intensity with each untimely death and is captured in the provocative Editorial "Death by Caffeine: How Many Caffeine-related Fatalities and Near-misses Must There Be before We Regulate?" published in Journal of Caffeine Research, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Caffeine Research website at liebertpub.com/jcr.

In his editorial, Jack E. James, PhD, Editor-in-Chief of Journal of Caffeine Research and Professor, Reykjavik University, Iceland and National University of Ireland, Galway, explores the "lethality of caffeine" and the proliferation of "the caffeinated environment," emphasizing in particular the risk posed by caffeine being added to energy drinks, bottled water, alcoholic drinks, candy, chewing gum, and yogurt, for example, and used in pain and cold/flu medications and powder and aerosol inhalers.

Dr. James draws attention to the "rising tide of concern expressed in the public media and scientific literature alike regarding the potential for caffeine-related harm." He notes that while some countries in Europe and Scandinavia have begun to take regulatory action, including sales restrictions and product labeling, the current "regulatory vacuum" in the United States "seems far from acceptable or prudent." A conversation is urgently needed to reach a consensus on a practical and effective framework for regulatory action.

About the Journal
Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science is a quarterly journal published in print and online that covers the effects of caffeine on a wide range of diseases and conditions, including mood disorders, neurological disorders, cognitive performance, cardiovascular disease, and sports performance. The Journal explores all aspects of caffeine science including the biochemistry of caffeine; its actions on the human body; benefits, dangers, and contraindications; and caffeine addiction and withdrawal, across all stages of the human life span from prenatal exposure to end-of-life. Complete tables of content and a sample issue may be viewed on the Journal of Caffeine Research website at liebertpub.com/jcr.

About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Breastfeeding Medicine, Journal of Medicinal Food, and Journal of Child and Adolescent Psychopharmacology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website at liebertpub.com.